Log In
BCIQ
Print this Print this
 

GED-aPC (LY458202)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionEngineered analog of recombinant human activated protein C (APC)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat cardiogenic shock (CS)
Regulatory Designation
PartnerCardiome Pharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today